| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A galactosidase-responsive doxorubicin-folate conjugate for selective targeting of acute myelogenous leukemia blasts
|
Clarhaut, Jonathan
|
|
2013
|
37 |
8 |
p. 948-955
8 p.
|
artikel
|
| 2 |
ARID5B and IKZF1 variants, selected demographic factors, and childhood acute lymphoblastic leukemia: A report from the Children's Oncology Group
|
Linabery, Amy M.
|
|
2013
|
37 |
8 |
p. 936-942
7 p.
|
artikel
|
| 3 |
Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts
|
van der Helm, L.H.
|
|
2013
|
37 |
8 |
p. 877-882
6 p.
|
artikel
|
| 4 |
CD11b expression correlates with monosomal karyotype and predicts an extremely poor prognosis in cytogenetically unfavourable acute myeloid leukemia
|
Juncà, Jordi
|
|
2013
|
37 |
8 |
p. 859-860
2 p.
|
artikel
|
| 5 |
CD11b expression correlates with monosomal karyotype and predicts an extremely poor prognosis in cytogenetically unfavourable acute myeloid leukemia
|
Chen, Mei-Hsi
|
|
2013
|
37 |
8 |
p. 861-
1 p.
|
artikel
|
| 6 |
CD47 is expressed abnormally on hematopoietic cells in myelodysplastic syndrome
|
Jiang, Huijuan
|
|
2013
|
37 |
8 |
p. 907-910
4 p.
|
artikel
|
| 7 |
Dose-intense etoposide–cyclophosphamide without stem cell transplantation for patients with intermediate and high cytogenetic risk primary refractory and relapsed acute myeloid leukemia
|
Trifilio, Steven
|
|
2013
|
37 |
8 |
p. 872-876
5 p.
|
artikel
|
| 8 |
Editorial Board
|
|
|
2013
|
37 |
8 |
p. CO2-
1 p.
|
artikel
|
| 9 |
Epigenetic action of decitabine (5-aza-2′-deoxycytidine) is more effective against acute myeloid leukemia than cytotoxic action of cytarabine (ARA-C)
|
Momparler, Richard L.
|
|
2013
|
37 |
8 |
p. 980-984
5 p.
|
artikel
|
| 10 |
Genetic predisposition to molecular response in patients with myeloproliferative neoplasms treated with hydroxycarbamide
|
Angona, Anna
|
|
2013
|
37 |
8 |
p. 917-921
5 p.
|
artikel
|
| 11 |
High expression of Musashi-2 indicates poor prognosis in adult B-cell acute lymphoblastic leukemia
|
Mu, Qitian
|
|
2013
|
37 |
8 |
p. 922-927
6 p.
|
artikel
|
| 12 |
Idarubicin appears equivalent to dose-intense daunorubicin for remission induction in patients with acute myeloid leukemia
|
Trifilio, Steven
|
|
2013
|
37 |
8 |
p. 868-871
4 p.
|
artikel
|
| 13 |
Linking genomic lesions with minimal residual disease improves prognostic stratification in children with T-cell acute lymphoblastic leukaemia
|
La Starza, Roberta
|
|
2013
|
37 |
8 |
p. 928-935
8 p.
|
artikel
|
| 14 |
MDR-1 and GST polymorphisms are involved in myelodysplasia progression
|
Palodetto, Bruna
|
|
2013
|
37 |
8 |
p. 970-973
4 p.
|
artikel
|
| 15 |
Molecular cytogenetic monitoring from CD34+ peripheral blood cells in myelodysplastic syndromes: First results from a prospective multicenter German diagnostic study
|
Braulke, Friederike
|
|
2013
|
37 |
8 |
p. 900-906
7 p.
|
artikel
|
| 16 |
Myelodysplastic syndromes and autoimmune diseases—Case series and review of literature
|
Ustwani, Omar Al
|
|
2013
|
37 |
8 |
p. 894-899
6 p.
|
artikel
|
| 17 |
Prognosis of acute myeloid leukemia transformed from myelodysplastic syndromes: A multicenter retrospective study
|
Okuyama, Namiko
|
|
2013
|
37 |
8 |
p. 862-867
6 p.
|
artikel
|
| 18 |
Prognosis of secondary acute myeloid leukemia
|
Della Porta, Matteo Giovanni
|
|
2013
|
37 |
8 |
p. 857-858
2 p.
|
artikel
|
| 19 |
Progressive burden of myelofibrosis in untreated patients: Assessment of patient-reported outcomes in patients randomized to placebo in the COMFORT-I study
|
Mesa, Ruben A.
|
|
2013
|
37 |
8 |
p. 911-916
6 p.
|
artikel
|
| 20 |
Retinoic acid induces adhesion and migration in NB4 cells through Pyk2 signaling
|
Ovcharenko, Adelina
|
|
2013
|
37 |
8 |
p. 956-962
7 p.
|
artikel
|
| 21 |
Safety and efficacy of 5-azacytidine treatment in myelodysplastic syndrome patients with moderate and mild renal impairment
|
Douvali, Evdoxia
|
|
2013
|
37 |
8 |
p. 889-893
5 p.
|
artikel
|
| 22 |
Scavenger receptor class A member 3 (SCARA3) in disease progression and therapy resistance in multiple myeloma
|
Brown, Charles O.
|
|
2013
|
37 |
8 |
p. 963-969
7 p.
|
artikel
|
| 23 |
The burden of symptoms in myelofibrosis: From patient-reported outcomes to health economics
|
Pieri, Lisa
|
|
2013
|
37 |
8 |
p. 855-856
2 p.
|
artikel
|
| 24 |
The prognostic impact of c-KIT mutation in systemic mastocytosis associated with acute myeloid leukaemia patients
|
Won, Dahae
|
|
2013
|
37 |
8 |
p. 883-888
6 p.
|
artikel
|
| 25 |
The utility of two prognostic models for predicting time to first treatment in early chronic lymphocytic leukemia patients: Results of a comparative analysis
|
Molica, Stefano
|
|
2013
|
37 |
8 |
p. 943-947
5 p.
|
artikel
|
| 26 |
XIAP downregulation promotes caspase-dependent inhibition of proteasome activity in AML cells
|
Carter, Bing Z.
|
|
2013
|
37 |
8 |
p. 974-979
6 p.
|
artikel
|
Tijdschrift beschrijving